Clean air and containment solutions business Envair Technology, has appointed Nick Davies as its Sales Director. Based at its 63,000 sq ft manufacturing facility and headquarters in Heywood, Greater Manchester, Nick joins the business with more than 20 years’ experience in senior leadership roles, bringing a proven track record of commercial growth and building high-performance teams.
The appointment comes at a time of sustained growth for Envair Technology, which is on track to exceed its £20m revenue target by 2030. Orders across its clean air product range, which includes isolators, fume cupboards and downflow booths, have risen by almost 20% over the past twelve months, with staff numbers also increasing by 15%.
This growth has been fuelled by demand for Annex 1-compliant equipment and isolators, driven by the shift to Vaporised Hydrogen Peroxide (VHP) gassing technology across NHS, healthcare and pharmaceutical markets. Investment in UK university laboratory infrastructure, as part of the government’s Science and Technology Superpower agenda, is also seeing demand for fume cupboards increase, with major projects underway and further large-scale developments planned.
Nick Davies joins Envair Technology from Medicom, where he supported the rollout of a major NHS mask contract during the Covid-19 pandemic and helped to establish the company as one of the top four FFP3 suppliers to the NHS. Prior to this, he spent 10 years at PPE specialist, Arco, working as a director in both divisional and national roles.
“Envair Technology is respected worldwide as a leading clean air and containment manufacturing specialist, and I’m delighted to join the team at such an exciting time”, says Nick Davies. “The company is serious about investing in growth – to deepen its sector expertise, enhance its manufacturing capability and further strengthen its aftermarket support services.
“My focus is on building a solutions-driven team that supports global organisations across the healthcare, pharmaceutical and education sectors - working in close partnership to enable the safe, compliant and effective handling of highly potent APIs and the advancement of next-generation drug development.”
Andrew Ellison, Managing Director of Envair Technology, adds: “Nick brings a wealth of experience in delivering sustained commercial growth within highly regulated markets. His deep understanding of our priority sectors, combined with his ability to build high-value relationships with world-leading organisations, makes him ideally placed to lead our next phase of growth. This is a pivotal year for Envair Technology as we continue to scale in the UK, Europe and beyond, and we’re delighted to have Nick on board.”